Meridian Bioscience (VIVO) Prelim. Q3 Revenue Misses Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Meridian Bioscience (VIVO) Prelim. Q3 Revenue Misses Consensus

Meridian Bioscience (VIVO) to Resume Trading at 7:45 a.m.

July 7, 2022 7:26 AM EDT

Meridian Bioscience (NASDAQ: VIVO) to Resume Trading at 7:45 a.m.

... More

Meridian Bioscience (VIVO) to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction, $34 Per Share

July 7, 2022 7:18 AM EDT

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, Inc. (KOSE: A137310) and SJL Partners LLC announced today that they have entered into a definitive merger agreement whereby a newly formed affiliate vehicle of the Consortium will acquire Meridian in an all-cash transaction valued at approximately $1.53 billion.

Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before the Consortium's first offer before... More

Meridian Bioscience (VIVO) Halted, News Pending

July 7, 2022 7:03 AM EDT

Meridian Bioscience (NASDAQ: VIVO) Halted, News Pending

... More